Publication Beamlines Strategic Pillar
Frigon, L.; Pascal, J.M. (2025). PARP4 BRCT domain F39A mutant. Protein Data Bank: 9dfr. CMCF-BM Health
Frigon, L.; Pascal, J.M. (2025). PARP4 BRCT domain F39Q mutant. Protein Data Bank: 9dfq. CMCF-BM Health
Frigon, L.; Pascal, J.M. (2025). PARP4 BRCT domain K23/24Q mutant. Protein Data Bank: 9dfp. CMCF-BM Health
Frigon, L.; Pascal, J.M. (2025). PARP4 BRCT domain K31Q mutant. Protein Data Bank: 9dfo. CMCF-BM Health
Gerak, C.A.N.; Kolesnikov, M.; Murphy, M.E.P.; McIntosh, L.P. (2021). Crystal structure of the monomeric ETV6 PNT domain. Protein Data Bank: 7ju2. CMCF-BM Health
Gorelik, A.; Illes, K.; Nagar, B. (2022). N-acetylglucosamine-1-phosphotransferase (GNPT) alpha and beta subunits (GNPTAB) catalytic domain, from zebrafish. Protein Data Bank: 7s6n. CMCF-BM Health
Grainger, R.; Colussi, D.C.; Noble, M.; Junop, M.; Stathopulos, P.B. et al. (2025). Human mitochondrial calcium uniporter crystal structure (residues 74-165 resolved) with lithium. Protein Data Bank: 8urg. CMCF-BM Health
Harris, S.F.; Wu, P. (2024). Mtb GuaB dCBS in complex with inhibitor compound 5. Protein Data Bank: 9dc9. CMCF-BM Health
Harris, S.F.; Wu, P. (2024). Mtb GuaB dCBS in complex with inhibitor G1. Protein Data Bank: 9dc8. CMCF-BM Health
Holyoak, T.; Tran, N. (2025). Staphylococcus aureus exfoliative toxin A D164E variant. Protein Data Bank: 9bsm. CMCF-BM Health
Holyoak, T.; Tran, N. (2025). Staphylococcus aureus exfoliative toxin A D164A variant. Protein Data Bank: 9bsh. CMCF-BM Health
Jin, L.; Padyana, A.K. (2022). "Crystal structure of human methionine adenosyltransferase 2A (MAT2A) in complex with SAM and allosteric inhibitor AGI-43192. Protein Data Bank: 7rwg. CMCF-BM Health
Kalthoff, E.; Schmeing, M. (2021). Crystal structure of the M. abscessus LeuRS editing domain in complex with epetraborole-AMP adduct. Protein Data Bank: 7n12. CMCF-BM Health
Khan, M.B.; Lu, J.; Arutyunova, E.; Young, H.S.; Lemieux, M.J. et al. (2021). Improved Feline Drugs as SARS-CoV-2 Mpro Inhibitors: Structure-Activity Studies & Micellar Solubilization for Enhanced Bioavailability. Protein Data Bank: 7lco. CMCF-BM Health
Khan, M.B.; Lu, J.; Arutyunova, E.; Young, H.S.; Lemieux, M.J. et al. (2021). Improved Feline Drugs as SARS-CoV-2 Mpro Inhibitors: Structure-Activity Studies & Micellar Solubilization for Enhanced Bioavailability. Protein Data Bank: 7ldl. CMCF-BM Health